Sunday, January 29, 2023 | Back issues
Courthouse News Service Courthouse News Service

Pfizer Wins Challenge |To Two Celebrex Patents

WASHINGTON (CN) - The Federal Circuit ruled for Pfizer on two of three patent claims covering the anti-inflammatory Celebrex that were challenged by the generic drug manufacturer Teva Pharmaceuticals USA. The three-judge panel found that two of the patents were valid, while the third was invalid due to double patenting.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.